Study identity card

Havlin

Czechia
Share
  • Disease: Respiratory syncytial virus infection
  • Study type: Observational Cohort Study, Prevention
  • Study type descriptors: Prospective, Single centre
  • Objective: To evaluate the immunogenicity and safety of the RSVPreF3-AS01 vaccine in lung transplant recipients aged 60 years and older
  • Number of participants enrolled: 30
  • Study enrolling from to
  • Study includes follow-up for 7 months

Study Data

  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Pharmacological intervention
  • Vaccination
  • Arexvy

Other information

Funders/Sponsors:

  • https://ror.org/05m8t8e28
  • https://ror.org/00y6khe77
  • https://ror.org/024d6js02

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to